Skip to main content
. 2023 Jun 12;10:1191315. doi: 10.3389/fmed.2023.1191315

Figure 10.

Figure 10

PLGA(RGF)-CXCR4L increase the percentage of apoptotic/dead cells 24 h after treatment. (A) Percentage of HCT116 colorectal cancer cells in apoptotic [Caspase-3/7 (+) and 7-AAD (−)] and Late Apoptotic/Dead [Caspase −3/7 (+) and 7-AAD (+)]. Error bars represent SEM. (B) Caspase −3/7 and 7-AAD analysis of HCT116 cells treated with PLGA(RGF)-CXCR4L for 24 h.